{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:47:02Z","timestamp":1765234022363,"version":"3.41.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,8]]},"DOI":"10.7759\/cureus.87513","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T12:47:29Z","timestamp":1751978849000},"source":"Crossref","is-referenced-by-count":1,"title":["Acute Promyelocytic Leukemia in a Patient With Sickle Cell Hemoglobin D Disease: A Case Report"],"prefix":"10.7759","author":[{"given":"Mahmoud","family":"Bokhary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra","family":"Turak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehab","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aly","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Abdelhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cigdem","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Sudha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leylagul","family":"Kaynar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-019-02160-x","article-title":"Sickle cell disease: a review for the internist","volume":"14","author":"Pinto VM","year":"2019","unstructured":"Pinto VM, Balocco M, Quintino S, Forni GL. Sickle cell disease: a review for the internist. Intern Emerg Med. 2019, 14:1051-64. 10.1007\/s11739-019-02160-x","journal-title":"Intern Emerg Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel FB","year":"2017","unstructured":"Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017, 376:1561-73. 10.1056\/NEJMra1510865","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato GJ","year":"2018","unstructured":"Kato GJ, Piel FB, Reid CD, et al.. Sickle cell disease. Nat Rev Dis Primers. 2018, 4:18010. 10.1038\/nrdp.2018.10","journal-title":"Nat Rev Dis Primers"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/BF00196236","article-title":"Hb D Los Angeles (D-Punjab) and Hb Presbyterian: analysis of the defect at the DNA level","volume":"84","author":"Schnee J","year":"1990","unstructured":"Schnee J, Aulehla-Scholz C, Eigel A, Horst J. Hb D Los Angeles (D-Punjab) and Hb Presbyterian: analysis of the defect at the DNA level. Hum Genet. 1990, 84:365-7. 10.1007\/BF00196236","journal-title":"Hum Genet"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)60608-8","article-title":"Facilitation of Hb S polymerization by the substitution of Glu for Gln at beta 121","volume":"263","author":"Adachi K","year":"1988","unstructured":"Adachi K, Kim J, Ballas S, Surrey S, Asakura T. Facilitation of Hb S polymerization by the substitution of Glu for Gln at beta 121. J Biol Chem. 1988, 263:5607-10.","journal-title":"J Biol Chem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees DC","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010, 376:2018-31. 10.1016\/S0140-6736(10)61029-X","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3109\/03630268408996969","article-title":"Life-threatening complications in a child with hemoglobin SD-Los Angeles disease","volume":"8","author":"Kelleher JF Jr","year":"1984","unstructured":"Kelleher JF Jr, Park JO, Kim HC, Schroeder WA. Life-threatening complications in a child with hemoglobin SD-Los Angeles disease. Hemoglobin. 1984, 8:203-13. 10.3109\/03630268408996969","journal-title":"Hemoglobin"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S14942","article-title":"Fetal hemoglobin reactivation and cell engineering in the treatment of sickle cell anemia","volume":"2","author":"Eridani S","year":"2011","unstructured":"Eridani S, Mosca A. Fetal hemoglobin reactivation and cell engineering in the treatment of sickle cell anemia. J Blood Med. 2011, 2:23-30. 10.2147\/JBM.S14942","journal-title":"J Blood Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2019.1647055","article-title":"Occurrence of acute myeloid leukemia in hydroxyurea-treated sickle cell disease patient","volume":"20","author":"Regan S","year":"2019","unstructured":"Regan S, Yang X, Finnberg NK, El-Deiry WS, Pu JJ. Occurrence of acute myeloid leukemia in hydroxyurea-treated sickle cell disease patient. Cancer Biol Ther. 2019, 20:1389-97. 10.1080\/15384047.2019.1647055","journal-title":"Cancer Biol Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2016.02.001","article-title":"Hematologic malignancies during pregnancy: a review","volume":"7","author":"Mahmoud HK","year":"2016","unstructured":"Mahmoud HK, Samra MA, Fathy GM. Hematologic malignancies during pregnancy: a review. J Adv Res. 2016, 7:589-96. 10.1016\/j.jare.2016.02.001","journal-title":"J Adv Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05294-3","article-title":"Sickle cell disease and acute leukemia: one case report and an extensive review","volume":"102","author":"Cannas G","year":"2023","unstructured":"Cannas G, Poutrel S, Heiblig M, Labussi\u00e8re H, Larcher MV, Thomas X, Hot A. Sickle cell disease and acute leukemia: one case report and an extensive review. Ann Hematol. 2023, 102:1657-67. 10.1007\/s00277-023-05294-3","journal-title":"Ann Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24010","article-title":"Myelodysplastic syndrome with clonal cytogenetic abnormalities followed by fatal erythroid leukemia after 14 years of exposure to hydroxyurea for sickle cell anemia","volume":"90","author":"Aumont C","year":"2015","unstructured":"Aumont C, Driss F, Lazure T, et al.. Myelodysplastic syndrome with clonal cytogenetic abnormalities followed by fatal erythroid leukemia after 14 years of exposure to hydroxyurea for sickle cell anemia. Am J Hematol. 2015, 90:E131-2. 10.1002\/ajh.24010","journal-title":"Am J Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/0141076816651037","article-title":"Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study","volume":"109","author":"Seminog OO","year":"2016","unstructured":"Seminog OO, Ogunlaja OI, Yeates D, Goldacre MJ. Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study. J R Soc Med. 2016, 109:303-9. 10.1177\/0141076816651037","journal-title":"J R Soc Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-783233","article-title":"Increased risk of leukemia among sickle cell disease patients in California","volume":"130","author":"Brunson A","year":"2017","unstructured":"Brunson A, Keegan TH, Bang H, Mahajan A, Paulukonis S, Wun T. Increased risk of leukemia among sickle cell disease patients in California. Blood. 2017, 130:1597-9. 10.1182\/blood-2017-05-783233","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0325-6","article-title":"Myeloid neoplasms in the setting of sickle cell disease: an intrinsic association with the underlying condition rather than a coincidence; report of 4 cases and review of the literature","volume":"32","author":"Li Y","year":"2019","unstructured":"Li Y, Maule J, Neff JL, et al.. Myeloid neoplasms in the setting of sickle cell disease: an intrinsic association with the underlying condition rather than a coincidence; report of 4 cases and review of the literature. Mod Pathol. 2019, 32:1712-26. 10.1038\/s41379-019-0325-6","journal-title":"Mod Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3462-y","article-title":"A monocentric retrospective study of 138 therapy-related myeloid neoplasms","volume":"97","author":"Claerhout H","year":"2018","unstructured":"Claerhout H, Lierman E, Michaux L, Verhoef G, Boeckx N. A monocentric retrospective study of 138 therapy-related myeloid neoplasms. Ann Hematol. 2018, 97:2319-24. 10.1007\/s00277-018-3462-y","journal-title":"Ann Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.60","article-title":"Therapy-related myeloid neoplasms: when genetics and environment collide","volume":"17","author":"McNerney ME","year":"2017","unstructured":"McNerney ME, Godley LA, Le Beau MM. Therapy-related myeloid neoplasms: when genetics and environment collide. Nat Rev Cancer. 2017, 17:513-27. 10.1038\/nrc.2017.60","journal-title":"Nat Rev Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.105","article-title":"Inflammation and cancer: advances and new agents","volume":"12","author":"Crusz SM","year":"2015","unstructured":"Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol. 2015, 12:584-96. 10.1038\/nrclinonc.2015.105","journal-title":"Nat Rev Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-12-200806170-00221","article-title":"Systematic review: hydroxyurea for the treatment of adults with sickle cell disease","volume":"148","author":"Lanzkron S","year":"2008","unstructured":"Lanzkron S, Strouse JJ, Wilson R, et al.. Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med. 2008, 148:939-55. 10.7326\/0003-4819-148-12-200806170-00221","journal-title":"Ann Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz169","article-title":"The IARC Monographs: updated procedures for modern and transparent evidence synthesis in cancer hazard identification","volume":"112","author":"Samet JM","year":"2020","unstructured":"Samet JM, Chiu WA, Cogliano V, et al.. The IARC Monographs: updated procedures for modern and transparent evidence synthesis in cancer hazard identification. J Natl Cancer Inst. 2020, 112:30-7. 10.1093\/jnci\/djz169","journal-title":"J Natl Cancer Inst"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/383816-acute-promyelocytic-leukemia-in-a-patient-with-sickle-cell-hemoglobin-d-disease-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T12:47:30Z","timestamp":1751978850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/383816-acute-promyelocytic-leukemia-in-a-patient-with-sickle-cell-hemoglobin-d-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.87513","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,8]]}}}